{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:43:30Z","timestamp":1791287010780,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.vaccine.2007.08.024","type":"journal-article","created":{"date-parts":[[2007,9,4]],"date-time":"2007-09-04T08:42:51Z","timestamp":1188895371000},"page":"7559-7567","source":"Crossref","is-referenced-by-count":242,"title":["Field effectiveness of vaccination against tick-borne encephalitis"],"prefix":"10.1016","volume":"25","author":[{"given":"Franz X.","family":"Heinz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidemarie","family":"Holzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Essl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2007.08.024_bib1","series-title":"Fields virology","first-page":"1043","article-title":"Flaviviruses","author":"Burke","year":"2001"},{"key":"10.1016\/j.vaccine.2007.08.024_bib2","series-title":"Fields Virology","first-page":"991","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2001"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.024_bib3","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1086\/515195","article-title":"Tick-borne encephalitis","volume":"28","author":"Dumpis","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.08.024_bib4","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0264-410X(02)00812-5","article-title":"Epidemiology and ecology of TBE relevant to the production of effective vaccines","volume":"21","author":"Suss","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.08.024_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1099\/0022-1317-80-1-179","article-title":"Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia","volume":"80","author":"Ecker","year":"1999","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.024_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0264-410X(92)90376-U","article-title":"Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes","volume":"10","author":"Holzmann","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.08.024_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0065-3527(03)61008-0","article-title":"Tick-borne flaviviruses","volume":"61","author":"Gritsun","year":"2003","journal-title":"Adv Virus Res"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.024_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jmv.20224","article-title":"Characterization of tick-borne encephalitis virus from Estonia","volume":"74","author":"Golovljova","year":"2004","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.024_bib9","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3201\/eid1210.060320","article-title":"Siberian subtype tickborne encephalitis virus, Finland","volume":"12","author":"Jaaskelainen","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2007.08.024_bib10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s10096-001-0637-5","article-title":"Tick-borne encephalitis virus in Lithuania","volume":"20","author":"Mickiene","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2007.08.024_bib11","unstructured":"The vector-borne human infections of Europe\u2014their distribution and burden on public health. In: WHO Regional Office for Europe (WHO\/EURO), Copenhagen, Denmark, 2004, pp. 37\u201353."},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.024_bib12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3201\/eid0906.030007","article-title":"Tick-borne encephalitis with hemorrhagic syndrome, Novosibirsk region, Russia, 1999","volume":"9","author":"Ternovoi","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"5\u20137","key":"10.1016\/j.vaccine.2007.08.024_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0934-8840(99)80006-1","article-title":"Main features of tick-borne encephalitis eco-epidemiology in Russia","volume":"289","author":"Korenberg","year":"1999","journal-title":"Zentralbl Bakteriol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.08.024_bib14","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0264-410X(02)00811-3","article-title":"Tick-borne encephalitis\u2014pathogenesis, clinical course and long-term follow-up","volume":"21","author":"Haglund","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.08.024_bib15","series-title":"Vaccines","first-page":"1039","article-title":"Tick-borne encephalitis virus vaccine","author":"Barrett","year":"2004"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.08.024_bib16","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0264-410X(02)00814-9","article-title":"History of TBE vaccines","volume":"21","author":"Barrett","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.024_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jmv.1890060304","article-title":"Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow zonal ultracentrifugation","volume":"6","author":"Heinz","year":"1980","journal-title":"J Med Virol"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.08.024_bib18","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0264-410X(02)00813-7","article-title":"TBE vaccination and the Austrian experience","volume":"21","author":"Kunz","year":"2003","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.024_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jmv.1890060202","article-title":"Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis","volume":"6","author":"Kunz","year":"1980","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.024_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0264-410X(92)90003-3","article-title":"A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens","volume":"10","author":"Harabacz","year":"1992","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.024_bib21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2310\/7060.2005.12205","article-title":"Protection against tick-borne encephalitis with a new vaccine formulation free of protein-derived stabilizers","volume":"12","author":"Zent","year":"2005","journal-title":"J Travel Med"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.024_bib22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2249.1997.4311446.x","article-title":"Antibodies protect mice against challenge with tick-borne encephalitis virus (TBEV)-infected macrophages","volume":"110","author":"Kreil","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.024_bib23","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1128\/JVI.71.4.2921-2927.1997","article-title":"Pre- and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model","volume":"71","author":"Kreil","year":"1997","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.024_bib24","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1128\/JVI.72.4.3076-3081.1998","article-title":"Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein","volume":"72","author":"Kreil","year":"1998","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2007.08.024_bib25","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3201\/eid0812.020229","article-title":"Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.024_bib26","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2007.08.024_bib27","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1128\/JVI.77.24.12941-12949.2003","article-title":"Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice","volume":"77","author":"Engle","year":"2003","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.024_bib28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1086\/376870","article-title":"Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice","volume":"188","author":"Ben-Nathan","year":"2003","journal-title":"J Infect Dis"},{"issue":"45","key":"10.1016\/j.vaccine.2007.08.024_bib29","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, September 2\u20133, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.08.024_bib30","first-page":"CD001269","article-title":"Vaccines for preventing influenza in healthy adults","volume":"2","author":"Jefferson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.08.024_bib31","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S1386-6532(06)80008-9","article-title":"Impact of hepatitis B vaccination on hepatitis B disease and nucleic acid testing in high-prevalence populations","volume":"36","author":"Chang","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2007.08.024_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/epirev\/mxj010","article-title":"Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched","volume":"28","author":"Chien","year":"2006","journal-title":"Epidemiol Rev"},{"issue":"RR-7","key":"10.1016\/j.vaccine.2007.08.024_bib33","first-page":"1","article-title":"Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Fiore","year":"2006","journal-title":"MMWR Recomm Rep"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2007.08.024_bib34","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0264-410X(02)00042-7","article-title":"Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years\u2019 followup after the Monroe field trial of VAQTA","volume":"20","author":"Werzberger","year":"2002","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.024_bib35","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"319","author":"Hoke","year":"1988","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.08.024_bib36","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S0264-410X(02)00819-8","article-title":"Diagnosis of tick-borne encephalitis","volume":"21","author":"Holzmann","year":"2003","journal-title":"Vaccine"},{"issue":"Suppl 37","key":"10.1016\/j.vaccine.2007.08.024_bib37","first-page":"5","article-title":"Evidence that climate change has caused \u2018emergence\u2019 of tick-borne diseases in Europe?","volume":"293","author":"Randolph","year":"2004","journal-title":"Int J Med Microbiol"},{"issue":"1454","key":"10.1016\/j.vaccine.2007.08.024_bib38","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1098\/rspb.2000.1204","article-title":"Fragile transmission cycles of tick-borne encephalitis virus may be disrupted by predicted climate change","volume":"267","author":"Randolph","year":"2000","journal-title":"Proc Biol Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.024_bib39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/path.2104","article-title":"Immunosenescence of ageing","volume":"211","author":"Gruver","year":"2007","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.024_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399407000221","article-title":"Age-related changes in immunity: implications for vaccination in the elderly","volume":"9","author":"Kovaiou","year":"2007","journal-title":"Exp Rev Mol Med"},{"issue":"25","key":"10.1016\/j.vaccine.2007.08.024_bib41","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2005.01.085","article-title":"Insufficient protection for healthy elderly adults by tetanus and TBE vaccines","volume":"23","author":"Hainz","year":"2005","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2007.08.024_bib42","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.exger.2006.09.005","article-title":"Immunity and ageing in man","volume":"41","author":"Pawelec","year":"2006","journal-title":"Exp Gerontol"},{"issue":"Pt 11","key":"10.1016\/j.vaccine.2007.08.024_bib43","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/brain\/122.11.2067","article-title":"The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994\u201398: a prospective study of 656 patients","volume":"122","author":"Kaiser","year":"1999","journal-title":"Brain"},{"issue":"Suppl 33","key":"10.1016\/j.vaccine.2007.08.024_bib44","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1438-4221(02)80012-1","article-title":"Tick-borne encephalitis (TBE) in Germany and clinical course of the disease","volume":"291","author":"Kaiser","year":"2002","journal-title":"Int J Med Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.024_bib45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0163-4453(95)91860-4","article-title":"Severe forms of tick-borne meningoencephalitis in Slovenia","volume":"31","author":"Pikelj","year":"1995","journal-title":"J Infect"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.024_bib46","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.vaccine.2004.07.002","article-title":"Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation","volume":"23","author":"Rendi-Wagner","year":"2004","journal-title":"Vaccine"},{"issue":"21\u201322","key":"10.1016\/j.vaccine.2007.08.024_bib47","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.vaccine.2004.01.041","article-title":"Persistence of protective immunity following vaccination against tick-borne encephalitis\u2014longer than expected?","volume":"22","author":"Rendi-Wagner","year":"2004","journal-title":"Vaccine"},{"issue":"Suppl 40","key":"10.1016\/j.vaccine.2007.08.024_bib48","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijmm.2006.01.030","article-title":"Persistence of antibodies after vaccination against tick-borne encephalitis","volume":"296","author":"Rendi-Wagner","year":"2006","journal-title":"Int J Med Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.024_bib49","first-page":"1","article-title":"Tick-borne encephalitis in Europe","volume":"60","author":"Kunz","year":"1992","journal-title":"Acta Leidensia"},{"key":"10.1016\/j.vaccine.2007.08.024_bib50","unstructured":"FSME. Risikogebiete in Deutschland. Epidemiologisches Bull. 2007;15:129\u201340."},{"key":"10.1016\/j.vaccine.2007.08.024_bib51","unstructured":"Zeckenenzephalitis (FSME): weitere Zunahme der gemeldeten F\u00e4lle im 2006. In: Bulletin BAG 2007, Epi Notiz, p. 57\u201360 (www.bag.admin.ch)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,26]],"date-time":"2020-04-26T04:25:28Z","timestamp":1587875128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07009474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":51,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0264410X07009474"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.08.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}